Azitra Eulerpool News

Azitra Stock News

Azitra is being monitored by journalists and investors worldwide. We gather the latest Azitra news here.

Azitra Stock Press Releases

Azitra regularly publishes news on the company's website that are relevant for investors.

Azitra News 2026

This page contains all current news, analysis and press releases for Azitra stock (AZTR, ISIN: US05479L3024). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at Azitra.

Azitra Stock

Azitra Azitra Inc., based in Branford, Connecticut, is an early-stage biopharmaceutical company focused on developing topical therapies for dermatological conditions. The company utilizes engineered proteins and live biotherapeutic products, leveraging a microbial library of 1,500 bacterial strains and AI-driven screening to create treatments for skin diseases. Its pipeline includes ATR-12 for Netherton syndrome, ATR-04 for papulopustular rash, and ATR-01 for ichthyosis vulgaris, all targeting unmet medical needs in precision dermatology. Listed on June 16, 2023, Azitra operates with a team of 10 employees.